ResearcherHouston MethodistNo recent work listed

Yulin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3479-9909. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2021: 2 papers

Papers 2

Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo. Last author DOI 10.1021/acs.jproteome.0c00666 ↗
Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells. Last author DOI 10.1186/s12885-021-07967-6 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nancy G. Azizian · 2 shared papers, 2021 · strength 0.31
- Paper Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells. DOI 10.1186/s12885-021-07967-6 ↗
- Paper Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo. DOI 10.1021/acs.jproteome.0c00666 ↗
Rong Du · 1 shared paper, 2021 · strength 0.17
- Paper Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells. DOI 10.1186/s12885-021-07967-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.